Search clinical trials for: ErbB2 positive
Total 11463 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingOral Cavity NeoplasmUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedNeoplasms, Gastrointestinal TractTaiwan, Korea, Republic of, China, Japan
-
Novartis PharmaceuticalsActive, not recruitingNeoplasms, Gastrointestinal TractChina, Canada, Estonia, Italy, Turkey, Argentina, Israel, Netherlands, Poland, Russian Federation, Thailand, Brazil, Chile, Hong Kong, Hungary, India, Mexico, Peru, Taiwan, Ukraine, United States, Korea, Republic of, Puerto Rico
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastSpain, United States, Argentina, Austria, Italy, Russian Federation, Thailand, Brazil, Peru, Philippines, Hong Kong, Mexico
-
GlaxoSmithKlineWithdrawn
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMetastases, BrainSpain, Hungary, Poland, Germany, Italy, Russian Federation, Sweden, United Kingdom, Thailand, United States, Belgium, France, Greece, Denmark
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Breast CancerKorea, Republic of, Taiwan, Hong Kong, United States, Japan, Croatia, United Kingdom, Hungary, Australia, Canada, Serbia, Singapore, South Africa, Poland, Spain, Russian Federation, Romania, Austria, Belgium, Bulgaria, Czechia, Fr... and more
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Bulgaria, Spain, Poland, Finland, United Kingdom, Austria, Italy, Greece, Czech Republic, Croatia
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Spain, Israel, Canada, Germany, Belgium, Austria, Sweden, Greece, France, Italy
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastUnited States, France, Ireland
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, Canada
-
GlaxoSmithKlineWithdrawnAdvanced Solid TumorsUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | KRAS Gene Mutation | Metastatic Malignant Solid Neoplasm | EGFR Gene Mutation | ERBB2 Gene Amplification | ERBB2 Gene Mutation | EGFR Gene Amplification | ERBB3 Gene Mutation | ERBB4 Gene MutationUnited States
-
China Medical University HospitalTerminated
-
Array Biopharma, now a wholly owned subsidiary...Completed
-
Array Biopharma, now a wholly owned subsidiary...Completed
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastBelgium, United States
-
GlaxoSmithKlineCompletedNeoplasms, BreastJapan
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedNeoplasms, BreastTaiwan, Peru, United States, Hong Kong, Chile, India, Mexico, Poland, Pakistan, Singapore, Malaysia
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Australia, Canada, Germany, Argentina, Poland, Russian Federation, Belgium, Spain, Latvia, Netherlands, New Zealand, Mexico, Pakistan, Italy, Austria, Chile, Peru, South Africa, Czech Republic, Hungary, Korea, Republic... and more
-
GlaxoSmithKlineTerminatedNeoplasms, Breast | Relapsed Breast CancerUnited States
-
National University Hospital, SingaporeNational Cancer Centre, SingaporeUnknownErbB2-Positive Stage I-III Breast CancerSingapore
-
GlaxoSmithKlineCompleted
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastSpain, Canada, United States, Australia, Austria, Italy, Japan, Poland, Sweden, France, Germany, Switzerland, Taiwan, United Kingdom, Belgium, Greece, India
-
BayerNot yet recruitingAdvanced Non-small Cell Lung Cancer | HER2 MutationUnited States, Korea, Republic of, Belgium, China, Japan, Taiwan, Denmark, Germany, Israel, Italy, United Kingdom, Bulgaria, Portugal, Switzerland, Greece, Turkey, Sweden, France, Singapore, Mexico, Spain, Netherlands, Poland, Brazil, A... and more
-
Seagen Inc.National Cancer Institute (NCI); Academic and Community Cancer Research UnitedCompletedMetastatic Colorectal AdenocarcinomaUnited States, Spain, Belgium, France, Italy
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States
-
Sun Yat-sen University307 Hospital of PLA; Fudan University; West China Hospital; Tongji Hospital; Second... and other collaboratorsCompletedStomach Neoplasms | ERBB2 Gene Amplification | Neoplasms MetastasisChina
-
GlaxoSmithKlineCompletedNeoplasms, BreastKorea, Republic of, Canada, United States
-
Duke UniversityGenentech, Inc.; Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
University of ZurichUnknownBreast Cancer | Metastatic Neoplasm | ERBB2Switzerland
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastRussian Federation, China, Brazil, Hong Kong, Pakistan, Peru, Thailand, Ukraine
-
Central European Cooperative Oncology GroupTerminatedMetastatic Breast CancerHungary, Austria
-
GlaxoSmithKlineCompletedSquamous Cell Carcinoma of Head and NeckSpain, France, Peru, India, Greece
-
Thomas GardnerJuvenile Diabetes Research Foundation; Penn State UniversityCompletedDiabetic RetinopathyUnited States
-
Puma Biotechnology, Inc.TerminatedMetastatic Cervical Cancer | Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerSpain, Israel, United States, Serbia, France, Ireland, Italy
-
University of PennsylvaniaWithdrawnBreast CancerUnited States
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Massachusetts General Hospital; Washington University School of Medicine; Gla... and other collaboratorsCompletedNeurofibromatosis 2 | Vestibular Schwannoma | Acoustic Neuroma | NF2 | Auditory TumorUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); PfizerTerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Breast Carcinoma Metastatic in the BrainUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastPoland, Russian Federation, Latvia, Romania
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Australia, Germany, Hungary, Poland, Peru, France, Israel, Russian Federation, Spain, Canada, Denmark, Hong Kong, Latvia, Korea, Republic of, China, Belgium, Philippines, Italy, United Kingdom, Argentina, India, New Zealand and more